141 related articles for article (PubMed ID: 11294398)
1. Different antagonist binding properties of human and rat histamine H3 receptors.
Stark H; Sippl W; Ligneau X; Arrang JM; Ganellin CR; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 2001 Apr; 11(7):951-4. PubMed ID: 11294398
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
3. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure.
Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S
J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032
[TBL] [Abstract][Full Text] [Related]
4. Dibasic non-imidazole histamine H3 receptor antagonists with a rigid biphenyl scaffold.
Morini G; Comini M; Rivara M; Rivara S; Lorenzi S; Bordi F; Mor M; Flammini L; Bertoni S; Ballabeni V; Barocelli E; Plazzi PV
Bioorg Med Chem Lett; 2006 Aug; 16(15):4063-7. PubMed ID: 16713264
[TBL] [Abstract][Full Text] [Related]
5. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
[TBL] [Abstract][Full Text] [Related]
6. Analogues and derivatives of ciproxifan, a novel prototype for generating potent histamine H3-receptor antagonists.
Stark H; Ligneau X; Sadek B; Ganellin CR; Arrang JM; Schwartz JC; Schunack W
Bioorg Med Chem Lett; 2000 Oct; 10(20):2379-82. PubMed ID: 11055360
[TBL] [Abstract][Full Text] [Related]
7. Reduction of CYP450 inhibition in the 4-[(1H-imidazol-4-yl)methyl]piperidine series of histamine H3 receptor antagonists.
Berlin M; Ting PC; Vaccaro WD; Aslanian R; McCormick KD; Lee JF; Albanese MM; Mutahi MW; Piwinski JJ; Shih NY; Duguma L; Solomon DM; Zhou W; Sher R; Favreau L; Bryant M; Korfmacher WA; Nardo C; West RE; Anthes JC; Williams SM; Wu RL; Susan She H; Rivelli MA; Corboz MR; Hey JA
Bioorg Med Chem Lett; 2006 Feb; 16(4):989-94. PubMed ID: 16297617
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling of histamine H3 receptor and QSAR studies on arylbenzofuran derived H3 antagonists.
Dastmalchi S; Hamzeh-Mivehroud M; Ghafourian T; Hamzeiy H
J Mol Graph Model; 2008 Jan; 26(5):834-44. PubMed ID: 17561422
[TBL] [Abstract][Full Text] [Related]
9. Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists.
Stark H; Kathmann M; Schlicker E; Schunack W; Schlegel B; Sippl W
Mini Rev Med Chem; 2004 Nov; 4(9):965-77. PubMed ID: 15544557
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and histamine H3 receptor activity of 4-(n-alkyl)-1H-imidazoles and 4-(omega-phenylalkyl)-1H-imidazoles.
De Esch IJ; Gaffar A; Menge WM; Timmerman H
Bioorg Med Chem; 1999 Dec; 7(12):3003-9. PubMed ID: 10658607
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.
Gfesser GA; Zhang H; Dinges J; Fox GB; Pan JB; Esbenshade TA; Yao BB; Witte D; Miller TR; Kang CH; Krueger KM; Bennani YL; Hancock AA; Faghih R
Bioorg Med Chem Lett; 2004 Feb; 14(3):673-6. PubMed ID: 14741266
[TBL] [Abstract][Full Text] [Related]
12. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
[TBL] [Abstract][Full Text] [Related]
13. A qualitative model for the histamine H3 receptor explaining agonistic and antagonistic activity simultaneously.
de Esch IJ; Timmerman H; Menge WM; Nederkoorn PH
Arch Pharm (Weinheim); 2000 Aug; 333(8):254-60. PubMed ID: 11008375
[TBL] [Abstract][Full Text] [Related]
14. Novel histamine H3 receptor antagonists based on the 4-[(1H-imidazol-4-yl)methyl]piperidine scaffold.
Vaccaro WD; Sher R; Berlin M; Shih NY; Aslanian R; Schwerdt JH; McCormick KD; Piwinski JJ; West RE; Anthes JC; Williams SM; Wu RL; She HS; Rivelli MA; Mutter JC; Corboz MR; Hey JA; Favreau L
Bioorg Med Chem Lett; 2006 Jan; 16(2):395-9. PubMed ID: 16246552
[TBL] [Abstract][Full Text] [Related]
15. Influence of bulky substituents on histamine h(3) receptor agonist/antagonist properties.
Sasse A; Ligneau X; Rouleau A; Elz S; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
J Med Chem; 2002 Aug; 45(18):4000-10. PubMed ID: 12190321
[TBL] [Abstract][Full Text] [Related]
16. Search for histamine H3 receptor antagonists with combined inhibitory potency at Ntau-methyltransferase: ether derivatives.
Apelt J; Grassmann S; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
Pharmazie; 2005 Feb; 60(2):97-106. PubMed ID: 15739896
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain.
Barocelli E; Ballabeni V; Chiavarini M; Bertoni S; Mor M; Plazzi PV; Bordi F; Impicciatore M
Inflamm Res; 2000 Apr; 49 Suppl 1():S62-3. PubMed ID: 10864424
[No Abstract] [Full Text] [Related]
18. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.
Kovalainen JT; Christiaans JA; Kotisaari S; Laitinen JT; Männistö PT; Tuomisto L; Gynther J
J Med Chem; 1999 Apr; 42(7):1193-202. PubMed ID: 10197963
[TBL] [Abstract][Full Text] [Related]
19. 1-alkyl-4-acylpiperazines as a new class of imidazole-free histamine H(3) receptor antagonists.
Zaragoza F; Stephensen H; Knudsen SM; Pridal L; Wulff BS; Rimvall K
J Med Chem; 2004 May; 47(11):2833-8. PubMed ID: 15139761
[TBL] [Abstract][Full Text] [Related]
20. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
